Drug Search Results

KP-415

Alternative Names: kp-415, kp 415, kp415, KP415 oral capsule
Latest Update: 2022-02-23
Latest Update Note: News Article

Product Description

Zevra Therapeutics is developing KP-415 as a treatment for attention-deficit/hyperactivity disorder (ADHD). (Sourced from: https://clinicaltrials.gov/ct2/show/NCT03292952)

Mechanisms of Action: CNS Stimulant

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Zevra
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Attention Deficit Disorder with Hyperactivity

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
KP415.S01	P3	Completed	Attention Deficit Disorder with Hyperactivity	2019-06-20
KP415.E01	P3	Completed	Attention Deficit Disorder with Hyperactivity	2018-05-16

Recent News Events

Date	Type	Title
02/23/2022	News Article	KemPharm Completes KP1077 Pre-IND Meeting Process with FDA
04/21/2021	News Article	KemPharm Confirms Receipt of $10 Million Milestone Payment for FDA Approval of AZSTARYS™ Per License Agreement with Affiliate of Gurnet Point Capital
04/08/2021	News Article	KemPharm Announces Amendment to Licensing Agreement with Gurnet Point Capital Affiliate Following FDA Approval of AZSTARYS™
03/04/2021	News Article	KemPharm to Present at the 33rd Annual Roth Conference

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions